Order Article Reprints

Zhou S, Zhao L, Liang Z, Liu S, Li Y, Liu S, Yang H, Liu M, Xi M. Indoleamine 2,3-dioxygenase 1 and Programmed Cell Death-ligand 1 Co-expression Predicts Poor Pathologic Response and Recurrence in Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy. Cancers. 2019; 11(2):169. https://doi.org/10.3390/cancers11020169

Zhou, Sha, Lei Zhao, Zhaohui Liang, Songran Liu, Yong Li, Shiliang Liu, Hong Yang, Mengzhong Liu, and Mian Xi. 2019. "Indoleamine 2,3-dioxygenase 1 and Programmed Cell Death-ligand 1 Co-expression Predicts Poor Pathologic Response and Recurrence in Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy" Cancers 11, no. 2: 169. https://doi.org/10.3390/cancers11020169

Zhou, S., Zhao, L., Liang, Z., Liu, S., Li, Y., Liu, S., Yang, H., Liu, M., & Xi, M. (2019). Indoleamine 2,3-dioxygenase 1 and Programmed Cell Death-ligand 1 Co-expression Predicts Poor Pathologic Response and Recurrence in Esophageal Squamous Cell Carcinoma after Neoadjuvant Chemoradiotherapy. Cancers, 11(2), 169. https://doi.org/10.3390/cancers11020169